Acurx Pharmaceuticals Inc (ACXP)

01:17 AM

Quantitative breakdown of Acurx Pharmaceuticals Inc. recent moveTrade Exit Summary & Entry Point Confirmation Alerts - newser.com

01:17 AM

Oct 12, 2025

Acurx Pharmaceuticals Inc.’s volatility index tracking explainedMarket Volume Summary & Weekly Momentum Stock Picks - newser.com

Oct 12, 2025

Oct 12, 2025

Can Acurx Pharmaceuticals Inc. (3ZO) stock test all time highsMarket Risk Report & Free High Accuracy Swing Entry Alerts - newser.com

Oct 12, 2025

Oct 11, 2025

New to The Street Broadcasts Tonight on Bloomberg Featuring Roadzen, Metaterra, NRx Pharma, Blackbarn NYC, and Humanitarian Travel Group - Myrtle Beach Sun News

Oct 11, 2025

Oct 11, 2025

Acurx Pharmaceuticals (NASDAQ:ACXP) Raised to Hold at Wall Street Zen - Defense World

Oct 11, 2025

Oct 10, 2025

How Acurx Pharmaceuticals Inc. (3ZO) stock reacts to fiscal policiesWeekly Profit Summary & Weekly High Conviction Trade Ideas - newser.com

Oct 10, 2025

Oct 09, 2025

Acurx Pharmaceuticals granted Australian patent for antibiotics - Investing.com Australia

Oct 09, 2025

Oct 09, 2025

Acurx Pharmaceuticals granted Australian patent for antibiotics By Investing.com - Investing.com Nigeria

Oct 09, 2025

Oct 09, 2025

Australian Patent Office Grants Acurx Patent for DNA Polymerase IIIC Inhibitors - Stock Titan

Oct 09, 2025

Oct 09, 2025

Measuring Acurx Pharmaceuticals Inc.’s beta against major indicesJuly 2025 Levels & Verified Swing Trading Watchlist - newser.com

Oct 09, 2025

Oct 08, 2025

What drives Acurx Pharmaceuticals Inc stock pricePrice-to-Earnings Ratio Insights & High Return Market Tips - earlytimes.in

Oct 08, 2025

Oct 08, 2025

Pharma Boom: Acurx on the Rise - StocksToTrade

Oct 08, 2025

Oct 08, 2025

ACXP’s Steady Climb: New Developments? - timothysykes.com

Oct 08, 2025

Oct 08, 2025

90% Plunge to 1000% Upside? Acurx Pharmaceuticals (ACXP) Stock Sees EMA Boost & Bold Analyst Predictions - ts2.tech

Oct 08, 2025

Oct 08, 2025

Why Confluent Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket - Benzinga

Oct 08, 2025

Oct 06, 2025

Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Resigns with New to The Street for Long-Form Interviews, National TV Commercials, Earned Media, and Accredited Investor Events - Corpus Christi Caller-Times

Oct 06, 2025

Oct 06, 2025

Will breakout in Acurx Pharmaceuticals Inc. lead to full recoveryPortfolio Update Summary & Daily Technical Stock Forecast Reports - newser.com

Oct 06, 2025

Oct 05, 2025

Acurx Pharmaceuticals Inc Stock Analysis and ForecastInterest Rate Changes & Build Capital Safely - earlytimes.in

Oct 05, 2025

Oct 05, 2025

How supply shortages influence Acurx Pharmaceuticals Inc. (3ZO) stockInsider Buying & Weekly Stock Performance Updates - newser.com

Oct 05, 2025

Oct 05, 2025

Acurx Pharmaceuticals Inc. stock trendline breakdownChart Signals & Long-Term Investment Growth Plans - newser.com

Oct 05, 2025

Oct 05, 2025

Why retail investors favor Acurx Pharmaceuticals Inc. stockPortfolio Gains Report & Reliable Breakout Stock Forecasts - newser.com

Oct 05, 2025

Oct 05, 2025

Will Acurx Pharmaceuticals Inc. stock outperform Nasdaq indexJuly 2025 Spike Watch & Daily Chart Pattern Signal Reports - newser.com

Oct 05, 2025

Oct 04, 2025

New to The Street to Broadcast Nationwide on Bloomberg Tonight at 6:30 PM EST - Sacramento Bee

Oct 04, 2025

Oct 04, 2025

Acurx Pharmaceuticals (NASDAQ:ACXP) Lowered to Sell Rating by Wall Street Zen - Defense World

Oct 04, 2025

Oct 03, 2025

Will Acurx Pharmaceuticals Inc. (3ZO) stock return to pre crash levels2025 Price Action Summary & Comprehensive Market Scan Insights - newser.com

Oct 03, 2025

Oct 03, 2025

Chart overlay techniques for tracking Acurx Pharmaceuticals Inc.2025 Support & Resistance & Consistent Profit Alerts - newser.com

Oct 03, 2025

Oct 01, 2025

Acurx Pharmaceuticals stock maintains Buy rating at H.C. Wainwright By Investing.com - Investing.com Nigeria

Oct 01, 2025

Oct 01, 2025

Acurx Pharmaceuticals stock maintains Buy rating at H.C. Wainwright - Investing.com

Oct 01, 2025

Oct 01, 2025

EMA approves Acurx’s pediatric plan for C. difficile drug ibezapolstat By Investing.com - Investing.com Nigeria

Oct 01, 2025

Oct 01, 2025

Acurx Pharmaceuticals (NASDAQ:ACXP) Given “Buy” Rating at HC Wainwright - Defense World

Oct 01, 2025

Sep 30, 2025

H.C. Wainwright Maintains Acurx Pharmaceuticals(ACXP.US) With Buy Rating, Maintains Target Price $31 - 富途牛牛

Sep 30, 2025

Sep 30, 2025

Promising Outlook for Acurx Pharmaceuticals: Buy Rating Driven by Regulatory Milestones and Clinical Success of Ibezapolstat - TipRanks

Sep 30, 2025

Sep 30, 2025

EMA approves Acurx’s pediatric plan for C. difficile drug ibezapolstat - Investing.com

Sep 30, 2025

Sep 30, 2025

Acurx Pharmaceuticals, Inc. Announces Positive Opinion from EMA on Pediatric Investigation Plan for Ibezapolstat Use in Children with C. Difficile Infection - MarketScreener

Sep 30, 2025

Sep 30, 2025

DYAI Stock Analysis and ForecastVolume Profile Analysis & Start Investing With Free Smart Watchlists - earlytimes.in

Sep 30, 2025

Sep 30, 2025

20,000 Children Affected Annually: Acurx's New Antibiotic Gets Key EMA Support for C. difficile Treatment - Stock Titan

Sep 30, 2025